Cargando…

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau

Mild cognitive impairment (MCI) can be an early manifestation of Alzheimer’s disease (AD) pathology, other pathologic entities [e.g., cerebrovascular disease, Lewy body disease, LATE (limbic-predominant age-related TDP-43 encephalopathy)], or mixed pathologies, with concomitant AD- and non-AD pathol...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCollum, Lauren E., Das, Sandhitsu R., Xie, Long, de Flores, Robin, Wang, Jieqiong, Xie, Sharon X., Wisse, Laura E.M., Yushkevich, Paul A., Wolk, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207301/ https://www.ncbi.nlm.nih.gov/pubmed/34119903 http://dx.doi.org/10.1016/j.nicl.2021.102717

Ejemplares similares

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
por: Duong, Michael Tran, et al.
Publicado: (2022)

Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
por: Xie, Long, et al.
Publicado: (2023)

DeepAtrophy: Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer’s disease
por: Dong, Mengjin, et al.
Publicado: (2021)

Regional Deep Atrophy: a Self-Supervised Learning Method to Automatically Identify Regions Associated With Alzheimer’s Disease Progression From Longitudinal MRI
por: Dong, Mengjin, et al.
Publicado: (2023)

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals
por: Groot, Colin, et al.
Publicado: (2022)

Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology
por: Ravikumar, Sadhana, et al.
Publicado: (2021)

Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology
por: Tanabe, Sean, et al.
Publicado: (2020)

Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults
por: Rodriguez-Vieitez, Elena, et al.
Publicado: (2021)

Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration
por: Wisse, L.E.M., et al.
Publicado: (2018)

The role of tau in neurodegeneration
por: Gendron, Tania F, et al.
Publicado: (2009)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
por: Iaccarino, Leonardo, et al.
Publicado: (2017)

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K, et al.
Publicado: (2017)

Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
por: Gijs, Marlies, et al.
Publicado: (2021)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021)

Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration
por: Drieu, Antoine, et al.
Publicado: (2023)

Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Hashimoto, Shoko, et al.
Publicado: (2019)

Tau and DNA Damage in Neurodegeneration
por: Colnaghi, Luca, et al.
Publicado: (2020)

Sleep spindles, tau, and neurodegeneration
por: Neylan, Thomas C, et al.
Publicado: (2022)

Tau as a Biomarker of Neurodegeneration
por: Holper, Sarah, et al.
Publicado: (2022)

Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K., et al.
Publicado: (2018)

Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2020)

Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia
por: Vipin, Ashwati, et al.
Publicado: (2022)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline
por: Zuroff, Leah, et al.
Publicado: (2022)

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2018)

β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population
por: Rosenberg, Anna, et al.
Publicado: (2022)

Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
por: Rao, Shalini S., et al.
Publicado: (2018)

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
por: Boyarko, Ben, et al.
Publicado: (2021)

Plasma phosphorylated tau181 predicts cognitive and functional decline
por: Tropea, Thomas F., et al.
Publicado: (2022)

An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
por: Trzeciakiewicz, Hanna, et al.
Publicado: (2020)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders
por: Ma, Ling-Zhi, et al.
Publicado: (2021)

Biomarkers of Inflammation Increase with Tau and Neurodegeneration but not with Amyloid-β in a Heterogenous Clinical Cohort
por: Michopoulou, Sofia, et al.
Publicado: (2022)

Aging-Related Tau Astrogliopathy in Aging and Neurodegeneration
por: McCann, Heather, et al.
Publicado: (2021)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Loss of tau rescues inflammation-mediated neurodegeneration
por: Maphis, Nicole, et al.
Publicado: (2015)

Early stages of tau pathology and its associations with functional connectivity, atrophy and memory
por: Berron, David, et al.
Publicado: (2021)

Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
por: Wisse, L. E. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vd651r9alnu8m385ls46hv5e9v